NEOS Investment Management LLC Purchases New Holdings in STERIS plc (NYSE:STE)

NEOS Investment Management LLC purchased a new stake in STERIS plc (NYSE:STEFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,408 shares of the medical equipment provider’s stock, valued at approximately $310,000.

Several other hedge funds have also made changes to their positions in STE. NBC Securities Inc. purchased a new stake in shares of STERIS in the 3rd quarter valued at approximately $50,000. Amalgamated Bank lifted its position in shares of STERIS by 1.8% in the 3rd quarter. Amalgamated Bank now owns 25,604 shares of the medical equipment provider’s stock valued at $5,618,000 after acquiring an additional 457 shares in the last quarter. Janney Montgomery Scott LLC lifted its position in shares of STERIS by 4.6% in the 3rd quarter. Janney Montgomery Scott LLC now owns 20,576 shares of the medical equipment provider’s stock valued at $4,515,000 after acquiring an additional 903 shares in the last quarter. Blueshift Asset Management LLC purchased a new stake in shares of STERIS in the 3rd quarter valued at approximately $220,000. Finally, Sequoia Financial Advisors LLC lifted its position in STERIS by 8.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,862 shares of the medical equipment provider’s stock worth $628,000 after buying an additional 234 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STE opened at $229.95 on Thursday. The company’s fifty day moving average is $216.76 and its 200-day moving average is $218.77. STERIS plc has a 12 month low of $195.47 and a 12 month high of $254.00. The firm has a market cap of $22.74 billion, a price-to-earnings ratio of 60.20 and a beta of 0.85. The company has a quick ratio of 2.36, a current ratio of 3.08 and a debt-to-equity ratio of 0.49.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 EPS for the quarter, topping the consensus estimate of $2.41 by $0.17. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the prior year, the business posted $2.30 EPS. STERIS’s quarterly revenue was up 10.8% on a year-over-year basis. Equities analysts expect that STERIS plc will post 9.27 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be paid a $0.52 dividend. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a yield of 0.90%. STERIS’s payout ratio is presently 54.45%.

Analysts Set New Price Targets

STE has been the subject of a number of research analyst reports. TheStreet upgraded shares of STERIS from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Friday, May 10th. StockNews.com downgraded shares of STERIS from a “buy” rating to a “hold” rating in a research report on Thursday, May 30th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, May 9th. Finally, Piper Sandler reiterated a “neutral” rating and issued a $225.00 target price (up previously from $220.00) on shares of STERIS in a research report on Friday, May 10th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $241.60.

Get Our Latest Stock Analysis on STE

Insider Activity at STERIS

In related news, SVP Cary L. Majors sold 2,024 shares of the firm’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $232.13, for a total value of $469,831.12. Following the transaction, the senior vice president now directly owns 11,369 shares in the company, valued at approximately $2,639,085.97. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other STERIS news, VP Renato Tamaro sold 1,154 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $231.64, for a total value of $267,312.56. Following the sale, the vice president now directly owns 6,677 shares in the company, valued at approximately $1,546,660.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Cary L. Majors sold 2,024 shares of the firm’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $232.13, for a total transaction of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares in the company, valued at $2,639,085.97. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,762 shares of company stock worth $1,798,477. 0.95% of the stock is owned by insiders.

STERIS Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

See Also

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.